Nuvalent, Inc. (NUVL)

100.50 -3.56 (-3.42%) USD  |  NASDAQ  |  Feb 20, 16:00
100.39 -0.11 (-0.11%) After-Hours: 20:00
More

Nuvalent Current Deferred Tax Liability (Quarterly)

Current Deferred Tax Liability (Quarterly) Chart

View Current Deferred Tax Liability (Quarterly) for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Tax Liability (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Tax Liability (Quarterly) Range, Past 5 Years

View Current Deferred Tax Liability (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Tax Liability (Quarterly) Benchmarks

View Current Deferred Tax Liability (Quarterly) Benchmarks
Start Trial
Glaukos Corp. --
Edgewise Therapeutics, Inc. --
Neurocrine Biosciences, Inc. --
Vanda Pharmaceuticals, Inc. --
Kodiak Sciences, Inc. --